ArticleSensors (Basel, Switzerland)2022
Telepresence Robot System for People with Speech or Mobility Disabilities.
Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Design and Evaluation of a Mobile App for Intergenerational Communication: User-Centered Participatory Design and Experimental Mixed Methods Study.JMIR aging · 2025Article
- Next Generation Computing and Communication Hub for First Responders in Smart Cities.Sensors (Basel, Switzerland) · 2024Article
- Robotic Pills as Innovative Personalized Medicine Tools: A Mini Review.Recent advances in drug delivery and formulation · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to an increase in the number of disabled people around the world, inclusive solutions are becoming a priority. People with disabilities may encounter many problems and may not be able to easily participate in various activities due to physical barriers, which may sometimes cause them to be frustrated and embarrassed. Recently, the emerging telepresence robot technology has been proposed to enable people with disabilities to increase their presence by incorporating information and communications technology (ICT) into robotics platforms. Therefore, in this paper we conduct a comprehensive analysis using comparative and elicitation studies to understand the current state of mobile telepresence robot systems and to identify the gaps that must be filled. This paper further contributes to the literature by proposing a novel telepresence robot system that adapts text-to-speech (TTS) and ICT technologies with robotics for its use as an assistant. To the authors' knowledge, the proposed system is the first MRP system that supports speech impairment and introduces emotion components into its communication function. It includes an operator site (mobile) and a remote site (robot) to allow users to control the robot from a distance and communicate with others in remote locations. It allows the user to physically interact with people and show certain emotions through the robot in remote locations, or it can accompany them to speak on their behalf. It can provide agency for both remote and in-class users through emoji-based communication and audio-video streaming with recording functionality. As shown at the end of this paper, the system was tested with 30 people, some of whom had mobility or speech disabilities, showing that the user acceptance score was above 95% and that people with disabilities liked to interact with other people using the proposed system. The users appreciated having the ability to control the robot from a distance and praised the capability to show their emotions through the robot emoji motions and to control the audio-video streaming. From this study, we conclude that the proposed telepresence system could be an asset to people with speech and mobility disabilities and could help them feel physically present in various places.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.